CD34+CELL YIELD ON DAY 1 OF APHERESIS PREDICTS TOTAL CD34+CELL MOBILIZATION, NEUTROPHIL RECOVERY, AND SURVIVAL AFTER AUTOLOGOUS STEM CELL TRANSPLANTATION FOR LYMPHOMA

被引：0
|
作者：
Dean, R. [1 ]
Rybicki, L. [1 ]
Pohlman, B. [1 ]
Sweetenham, J. [1 ]
Sobecks, R. [1 ]
Copelan, E. [1 ]
Kalaycio, M. [1 ]
Smith, S. [1 ]
andresen, S. [1 ]
Bolwell, B. [1 ]
机构：
[1] Cleveland Clin, Taussig Canc Inst, Cleveland, OH 44106 USA
来源：
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION | 2009年 / 15卷 / 02期
关键词：
D O I：
10.1016/j.bbmt.2008.12.115
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
93
引用
收藏
页码：38 / 38
页数：1
相关论文
共 50 条
  • [41] CD34+cell selection has no impact on the outcome of autologous blood stem cell transplantation (ABSCT) in multiple myeloma (MM)
    Remes, K
    Itälä, M
    Kauppila, M
    Pelliniemi, TT
    Rajamäki, A
    BONE MARROW TRANSPLANTATION, 2002, 29 : S97 - S97
  • [42] Pre-Apheresis Prediction of CD34+Cell Yield from Collecting Efficiency Is Not Reliable in Peripheral Blood Stem Cell Collection
    Yamazaki, Rie
    Igarashi, Yasuhiro
    Matsuhashi, Hiroko
    Hibayashi, Noriyuki
    Kato, Jun
    Kataoka, Keisuke
    Tanosaki, Ryuji
    BLOOD, 2023, 142
  • [43] Assessment of CD34+cell viability at thaw/infusion for dual-unit cord blood transplantation: Correlation of viable CD34+cell dose with engraftment
    Vasileiou, S.
    Baltadakis, I.
    Panitsas, F.
    Tzannou, I.
    Poulopoulou, Z.
    Bika, I.
    Papageorgiou, M.
    Karatza, M. -E
    Garofalaki, M.
    Tziotziou, E.
    Bouzani, M.
    Gigantes, S.
    Apostolidis, J.
    Harhalakis, N.
    Karakasis, D.
    BONE MARROW TRANSPLANTATION, 2015, 50 : S353 - S353
  • [44] FACTORS AFFECTING CD34+CELL PURITY, CD34+CELL RECOVERY, AND LOG T CELL DEPLETION OF PRODUCTS PROCESSED FOR CD34-ENRICHMENT ON THE ISOLEX(sic) CELL SEPARATION DEVICE. A SINGLE CENTER EXPERIENCE
    Keever-Taylor, C. A.
    Zhang, L.
    Konings, S.
    Skonecki, J. A.
    Zheng, H.
    Heidtke, S. A.
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2010, 16 (02) : S211 - S211
  • [45] CD34+Cell Dose Influences Survival after Allogeneic Peripheral Blood Stem Cell Transplantation with Post-Transplant Cyclophosphamide
    Elmariah, Hany
    Naqvi, Syeda Mahrukh Hussnain
    Kim, Jongphil
    Nishihori, Taiga
    Mishra, Asmita
    Perez, Lia
    Liu, Hien D.
    Khimani, Farhad
    Nieder, Michael
    Pidala, Joseph
    Bejanyan, Nelli
    BLOOD, 2019, 134
  • [46] CD34+cell analysis: Multicenter cooperative trials
    Dzik, S
    MOLECULAR BIOLOGY IN BLOOD TRANSFUSION, 2000, 35 : 147 - 158
  • [47] High CD34+cell dose is associated with increased early mortality after allogeneic hematopoietic stem cell transplantation
    Neumann, K.
    Lange, S.
    Kragl, B.
    Glass, Ae
    Grosse-Thie, C.
    Wittke, C.
    Freitag, S.
    Henze, L.
    Kleine, H. -D
    Junghanss, C.
    ONCOLOGY RESEARCH AND TREATMENT, 2016, 39 : 80 - 80
  • [48] CD34+cell dose predicts relapse and survival after T-cell-depleted HLA-identical haematopoietic stem cell transplantation (HSCT) for haematological malignancies
    Bahçeci, E
    Read, EJ
    Leitman, S
    Childs, R
    Dunbar, C
    Young, NS
    Barrett, AJ
    BRITISH JOURNAL OF HAEMATOLOGY, 2000, 108 (02) : 408 - 414
  • [49] The Impact of CD34+Cell Collection Yields for Autologous Transplant on Survival Outcomes in Multiple Myeloma
    Lebel, Eyal
    Lajkosz, Katherine
    Masih-Khan, Esther
    Reece, Donna
    Trudel, Suzanne
    Tiedemann, Rodger
    Prica, Anca
    Kukreti, Vishal
    Chen, Christine
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2023, 23 (11): : 850 - 856
  • [50] Significant correlation between peripheral blood CD34+cell count in children prior to aphaeresis, and CD34+cell yield following aphaeresis - single center experience
    Keidar, H. Rosenfeld
    Eshel, R.
    Pinhasov, A.
    Bitan, M.
    Edelman, S.
    Broitman, M.
    Abu Yaman, M.
    Dvir, R.
    Sadot, E.
    Levine, D.
    Manisterski, M.
    Achituv, S.
    Ronit, E.
    BONE MARROW TRANSPLANTATION, 2016, 51 : S266 - S266
12345